학술논문

Long-term patient-important outcomes after septic shock: A protocol for 1-year follow-up of the CLASSIC trial.
Document Type
Journal Article
Source
Acta Anaesthesiologica Scandinavica. Mar2020, Vol. 64 Issue 3, p410-416. 7p.
Subject
*SEPTIC shock
*MONTREAL Cognitive Assessment
*FLUID therapy
*INTRAVENOUS therapy
*SHOCK therapy
*EXPERIMENTAL design
*TIME
*QUALITY of life
*RESEARCH funding
*LONGITUDINAL method
*DISEASE complications
Language
ISSN
0001-5172
Abstract
Background: In patients with septic shock, mortality is high, and survivors experience long-term physical, mental and social impairments. The ongoing Conservative vs Liberal Approach to fluid therapy of Septic Shock in Intensive Care (CLASSIC) trial assesses the benefits and harms of a restrictive vs standard-care intravenous (IV) fluid therapy. The hypothesis is that IV fluid restriction improves patient-important long-term outcomes.Aim: To assess the predefined patient-important long-term outcomes in patients randomised into the CLASSIC trial.Methods: In this pre-planned follow-up study of the CLASSIC trial, we will assess all-cause mortality, health-related quality of life (HRQoL) and cognitive function 1 year after randomisation in the two intervention groups. The 1-year mortality will be collected from electronic patient records or central national registries in most participating countries. We will contact survivors and assess EuroQol 5-Dimension, -5-Level (EQ-5D-5L) and EuroQol-Visual Analogue Scale and Montreal Cognitive Assessment 5-minute protocol score. We will analyse mortality by logistic regression and use general linear models to assess HRQoL and cognitive function.Discussion: With this pre-planned follow-up study of the CLASSIC trial, we will provide patient-important data on long-term survival, HRQoL and cognitive function of restrictive vs standard-care IV fluid therapy in patients with septic shock. [ABSTRACT FROM AUTHOR]